SVAR
LIVE

Serial Number

79241657

Owner

SVAR Life Science AB

Attorney

Maurine Knutsson

Filing Date

May 11, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SVAR Trademark

Serial Number: 79241657 • Registration: 5736546

SVAR is a trademark filed by SVAR Life Science AB on May 11, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SVAR Life Science AB (5 trademarks)

Box 50117

Entity Type: 09

Euro-Diagnostica AB (5 trademarks)

Medeon

Entity Type: 09

Trademark Details

Filing Date

May 11, 2018

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Goods & Services

[ Instruments for use in performing cell-based assays by means of optic detection, namely, optical inspection apparatus; computer software for use in performing optic based biological analysis; computer software for use in performing optic based biological analysis, and for using tools during drug development, clinical diagnosis, clinical monitoring or assay development; computer application software for mobile phones and handheld computers, namely, software for patient monitoring; apparatus for recording, transmission and reproduction of sound and images; blank magnetic data carriers; digital recording media, namely, blank digital storage media ]

[ Medical diagnostic apparatus for testing assays; medical equipment, namely, apparatus for analysing blood ]

[ Telecommunication services, namely, transmission of voice, data, graphics, images, audio and video by means of telecommunications networks, wireless communication networks, and the Internet; providing access to portals on the internet ]

Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic and analytical substances for medical and veterinary purposes, in particular, laboratory diagnostic kits comprised of medical diagnostic reagents, anti-bodies, and immunochemicals for use in disease detection in the area of medical prevention

Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes [ ; medical services, namely, treating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services ]

Substances for use in cell-based reporter gene assays, namely, assays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposes, namely, reagents for scientific and research use; reagents for chemical analyses, namely, chemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research use, namely, cell-lines; components for cell-based analyses using optical methods and containing chemical reagents, namely, cells for scientific and research use; chemical preparations for the laboratory and for scientific, diagnostic and analytical purposes, other than for medical or veterinary use

Cell-based assay services, namely, custom design and development of cell-based biochemical assays; cell-based assay services, namely, custom design and development of cell-based biochemical assays for use in drug development, clinical diagnosis, clinical monitoring or assay development; medical research; clinical research in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; [ conducting clinical trials for others; ] laboratory research and analysis services in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific laboratory testing services; [ research in the fields of medicine and data analytics; ] providing scientific diagnostic services for others in the fields of drug development, clinical diagnosis, clinical monitoring or assay development [ ; testing of chemical preparations and cells for diagnostic purposes ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 17, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 17, 2025 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 17, 2025 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2025 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Mar 7, 2025 NREP
TEAS SECTION 71 & 15 RECEIVED
Feb 25, 2025 ES75
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 5, 2020 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 15, 2020 INPR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 2, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 26, 2019 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Aug 15, 2019 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Aug 15, 2019 COC.
ASSIGNED TO PARALEGAL
Aug 15, 2019 PLGL
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
LIMITATION OF GOODS RECEIVED FROM IB
Feb 1, 2019 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTICE OF PUBLICATION
Jan 23, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2018 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 23, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 23, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 12, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 11, 2018 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 11, 2018 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 11, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 10, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 9, 2018 MAFR
ASSIGNED TO EXAMINER
Oct 3, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 27, 2018 REPR